参考文献/References:
[1] BHATT P,VHORA I,PATIL S,et al.Role of antibodies in diagnosis and treatment of ovarian cancer:basic approach and clinical status[J].Control Release,2016,226:148-167.
[2] 张镛镛,王芳,雷利娜,等.血清高迁移率族蛋白A2、糖链抗原19-9联合ROMA指数对卵巢癌的诊断价值[J].新乡医学院学报,2020,37(5):471-474.
[3] 吴丹,王建东.YAP的生物学功能及其与卵巢癌相关性研究进展[J].癌症进展,2017,15(8):851-853.
[4] 高巍,宋平义,景桂霞,等.丙泊酚对HepG2肝母细胞瘤细胞侵袭能力的影响[J].郑州大学学报(医学版),2015,50(3):318-322.
[5] XU Y J,LI S Y,CHENG Q,et al.Effects of anaesthesia on proliferation,invasion and apoptosis of LoVo colon cancer cells in vitro[J].Anaesthesia,2016,71(2):147-154.
[6] LI H,LU Y,PANG Y,et al.Propofol enhances the cisplatin-induced apoptosis on cervical cancer cells via EGFR/JAK2/STAT3 pathway[J].Biomed Pharmacother,2017,86:324-333.
[7] YU X,GAO Y,ZHANG F.Propofol inhibits pancreatic cancer proliferation and metastasis by up-regulating miR-328 and down-regulating ADAM8[J].Basic Clin Pharmacol Toxicol,2019,125(3):271-278.
[8] 杨国庆,刘德军.丙泊酚通过MAPK/ERK途径抑制食管癌细胞系EC9706中VEGF的表达[J].医学研究杂志,2017,46(12):90-94.
[9] 李鸿涛,于婵娟,刘亚华,等.丙泊酚对乳腺肿瘤细胞磷酸肌醇3-激酶/丝氨酸蛋白激酶信号通路的影响[J].中华实验外科杂志,2017,34(4):552-554.
[10] WIGMORE T J,MOHAMMED K,JHANJI S.Long-term survival for patients undergoing volatile versus IV anesthesia for cancer surgery:a retrospective analysis[J].Anesthesiology,2016,124(1):69-79.
[11] LIU S,GU X,ZHU L,et al.Effects of propofol and sevoflurane on perioperative immune response in patients undergoing laparoscopic radical hysterectomy for cervical cancer[J].Medicine,2016,95(49):e5479.
[12] JIANG S,LIU Y,HUANG L,et al.Effects of propofol on cancer development and chemotherapy:potential mechanisms[J].Eur J Pharmacol,2018,831:46-51.
[13] LI X,YAO L,LIANG Q,et al.Propofol protects hippocampal neurons from hypoxia-reoxygenation injury by decreasing calcineurin-induced calcium overload and activating YAP signaling[J].Oxid Med Cell Longev,2018,2018:1725191.
[14] WU L,LING Z H,WANG H,et al.Upregulation of SCNN1A promotes cell proliferation,migration,and predicts poor prognosis in ovarian cancer through regulating epithelial-mesenchymal transformation[J].Cancer Biother Radiopharm,2019,34(10):642-649.
[15] YANG Y,PARK H,YANG Y,et al.Enhancement of cell migration by corticotropin-releasing hormone through ERK1/2 pathway in murine melanoma cell line,B16F10[J].Exp Dermatol,2007,16(1):22-27.
[16] PUJADA A,WALTER L,PATEL A,et al.Matrix metalloproteinase MMP9 maintains epithelial barrier function and preserves mucosal lining in colitis associated cancer[J].Oncotarget,2017,8(55):94650-94665.
[17] GROBLEWSKA M,SIEWKO M,MROCZKO B,et al.The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer[J].Folia Histochem Cytobiol,2012,50(1):12-19.
[18] SUN X,LIN L,CHEN Y,et al.Nitidine chloride inhibits ovarian cancer cell migration and invasion by suppressing MMP-2/9 production via the ERK signaling pathway[J].Mol Med Rep,2016,13(4):3161-3168.
[19] MANTIONE M E,LOMBARDI M,BACCELLIERI D,et al.IL-1β/MMP9 activation in primary human vascular smooth muscle-like cells:exploring the role of TNFα and P2X7[J].Int J Cardiol,2019,278:202-209.